Switch to हिंदी

Health, Fitness, Beauty & Diet | Pregnancy & Parenting | Diseases & Home Remedies | TheHealthSite.com

हिंदी
  • Health A-Z
  • Home Remedies
  • Diseases
    • Type 1 Diabetes
    • Type 2 Diabetes
    • Cancer
    • Heart Attack
    • Pneumonia
    • Diseases A-Z
  • Diet & Fitness
    • Weight Management
    • Exercise & Body Building
    • Diet & Recipes
    • Yoga
  • Coronavirus
  • News
  • Pregnancy
    • Conceiving
    • Infertility
    • Labour & Delivery
    • Pregnancy week-by-week
    • Breastfeeding
    • Baby Names
  • Beauty
    • Skin
    • Hair
    • Grooming
  • Photos
  • Videos
Home / Health News / 63% not willing to pay over Rs 600 for COVID-19 vaccine

63% not willing to pay over Rs 600 for COVID-19 vaccine

A new survey suggests that the majority of people will not pay over Rs 600 for the COVID-19 vaccination available in India.

By: Arushi Bidhuri   | | Updated: February 27, 2021 2:29 pm
Tags: Coronavirus  covid vaccine  COVID-19  

A survey by LocalCircles has revealed that 63 per cent of the people planning to take the coronavirus vaccine in the next phase starting March 1 in private hospitals will not pay more than 600 Indian rupees for the two vaccine doses. The poll tried to understand the tentative perception of how much people are willing to pay if they are eligible to get the vaccine in the next phase. As per the survey, 17 per cent of people are willing to pay “up to Rs 200,” 22 per cent were willing to pay “up to 300,” 24 per cent said that they would pay “up to Rs 600,” 16 per cent said “up to Rs 1000,” and 6 per cent said, “above Rs 1000.” Also Read - COVID-19 Second Wave: Experts Suggest Strict Lockdown In India To Break Coronavirus Chain

According to the findings, 63 per cent of the people surveyed were willing take the coronavirus vaccine in the next phase at a private hospital only if it is available under Rs 600 in total charges for two doses. The results also pointed out that 21 per cent of citizens are ready to have their qualifying family members get the vaccine at a private hospital based on payment and how the vaccination drive progresses. 27 per cent are currently unsure if they want to opt for this vaccine through the same channel. Also Read - Kumbh Mela Haridwar: Over 1000 Tests Positive For COVID-19 In 48 Hrs After Taking Holy Dip



COVID-19 Vaccine: Black Marketing, Wastage And Hospital Management Another Concern

Apart from the pricing, many people are concerned about the steps that are being undertaken to reduce vaccine black marketing, wastage, hospital marketing and doctor discretion on who will be vaccinated first. In light of this concern, the majority of people want to take the vaccine at a government centre. Only 21 per cent of the people said they would take it “through a private hospital.” Some people have not decided where to get the vaccination from, 27 per cent to be exact. Also Read - Out of the tri-doshas, which are responsible for COVID-19 infection?

As per the survey, people might opt for private hospitals once the vaccination drive takes off. The private healthcare sector provides for 75 per cent of outpatient care and 55 per cent of inpatient care in India. The government of India has decided to allow nearly 24,000 private hospitals across the country to start inoculation of Covishield and Covaxin vaccines in the next round of vaccination programme, which is to begin in March. In the coming drive, citizens over 60 years of age, and 45-year-old people with comorbidities will be eligible for the vaccines.

NITI Aayog Propose Vax Price Between Rs 300-500

NITI Aayog has promulgated a price range of Rs 300-500 for two COVID vaccines that would be available for the priority group at private facilities in the third phase of vaccination set to begin from March 1. The third phase of vaccination will cover 27 crore people at 10,000 government and over 20,000 private vaccination centres.

(with inputs from IANS) 

Published : February 27, 2021 2:25 pm | Updated:February 27, 2021 2:29 pm
Read Disclaimer

Centre fixes COVID-19 vaccination price at Rs 250 per dose for private vaccination centres, but with a rider

Centre fixes COVID-19 vaccination price at Rs 250 per dose for private vaccination centres, but with a rider

India records over 16k fresh COVID-19 cases, 113 deaths in last 24 hrs

India records over 16k fresh COVID-19 cases, 113 deaths in last 24 hrs

Please Wait. Article Loading ....

Coronavirus Updates

Coronavirus Updates

Stay Informed, Be Safe

  • COVID-19 Second Wave: Experts Suggest Strict Lockdown In India To Break Coronavirus Chain
  • Sputnik V: How Does This COVID-19 Vaccine Works And Who All Can Take The Jab
  • Man Dies Minutes After Taking First Dose Of Pfizer COVID-19 Vaccine; Here's What To Know Before Taking The Jab
  • Kumbh Mela Haridwar: Over 1000 Tests Positive For COVID-19 In 48 Hrs After Taking Holy Dip
  • Out of the tri-doshas, which are responsible for COVID-19 infection?

Health Calculators

BMI Calculator
bmi Calculator
Ideal Body Weight
ideal body weight
Daily Calorie Intake
Daily calorie intake
Calories Burned
calories burned

Related Stories

Sputnik V gets a nod from Indian authorities for emergency use: Sources

Sputnik V gets a nod from Indian authorities for emergency use: Sources

India set to welcome third Covid-19 vaccine - Sputnik V

India set to welcome third Covid-19 vaccine - Sputnik V

Shocking! 3 women given anti-rabies jab instead of Covid vaccine in Shamli, UP

Shocking! 3 women given anti-rabies jab instead of Covid vaccine in Shamli, UP

Covid-19 vaccine shortage reported across Delhi, Maharashtra and other states; Should you be worried?

Covid-19 vaccine shortage reported across Delhi, Maharashtra and other states; Should you be worried?

Can your fancy mask protect you against Covid? Layering, fitting and material matters

Can your fancy mask protect you against Covid? Layering, fitting and material matters

Health News in Hindi

UP Quarantine Guidelines: कोरोना संकट के बीच वापस यूपी जा रहे हैं तो जान ले यहां के नए क्वारंटाइन निय‍म

करीना कपूर को दूसरी प्रेगनेंसी में बार-बार हो रही थी इन अनहेल्दी चीज़ों की क्रेविंग, बेबो ने खुद किया खुलासा

Epilepsy Awareness: वीडियो की मदद से मिर्गी से जुड़े मिथकों और भ्रांतियों को दूर करें

Weekend Curfew In Delhi: दिल्‍ली में लगा वीकेंड कर्फ्यू, जानें क्या खुलेगा और किन चीजों पर रहेगी पाबंदी

महाराष्ट्र में हुआ कोरोना का डबल म्यूटेशन, क्या आने वाले दिनों में कोरोना संक्रमण हो सकता है और भी गम्भीर ?

Read All

Recent Posts

  • Beat the heat this season! Expert reveals 5 cooling foods to eat this summer
  • Should Delhi Impose 3-Week Lockdown to Curb COVID-19 Surge? 59% Residents Say ‘Yes’
  • Arvind Kejriwal Govt Announces Weekend Curfew In Delhi Amid COVID-19 Surge, Allows Passes For Essential Services
  • Epilepsy Awareness: Dispelling the myths and misconceptions associated with this disease
  • Safe Workout For People With Pulmonary Heart Disease: Watch the Video Here

About The health Site

TheHealthSite.com is India's largest health site with more than 40 lakh unique visitors per month. We focus on fitness, beauty, health, pregnancy and more.

Most popular health and wellness website in India in 2012 at the Website of the year awards.

health@corp.india.com
+91 – 22 – 6697 1234
Landline Phone number 91 – 22 – 2490 0302.

ZEE ENTERTAINMENT ENTERPRISES LTD, 18th floor, A-Wing, Marathon Futurex, N. M. Joshi Marg, Lower Parel, Mumbai, Maharashtra 400013.

Useful Links

  • Weight Loss
  • Keto Diet Tips
  • Skin Care Tips
  • Intermittent Fasting
  • Apple Cider Vinegar
  • Ashwagandha
  • Cancer
  • Pneumonia
  • Diarrhoea
  • Dengue
  • Typhoid
  • Tuberculosis
  • Chickenpox
  • Chikungunya
  • Depression
  • Hepatitis
  • Diabetes
  • Type 2 diabetes
  • Arthritis
  • Swine Flu
  • Baby Names
  • Cough and cold
  • Heart Attack
  • Breast Cancer
  • Ebola Virus
  • Dengue
  • Malaria
  • International Yoga Day
  • Hypotension
  • Heart Failure
  • Asthma
  • Brain Tumour
  • Celebrity Fitness
  • Goitre
  • HIV/AIDS

We respect your privacy

  • Disclaimer
  • Privacy Policy
  • Contact Us
  • Author Profiles

Copyright © 2021 Zee Entertainment Enterprises Limited. All rights reserved.